[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Neprilysin-South America Market Status and Trend Report 2013-2023

May 2018 | 146 pages | ID: NAE883044B1MEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Neprilysin-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Neprilysin industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole South America and Regional Market Size of Neprilysin 2013-2017, and development forecast 2018-2023
Main market players of Neprilysin in South America, with company and product introduction, position in the Neprilysin market
Market status and development trend of Neprilysin by types and applications
Cost and profit status of Neprilysin, and marketing status
Market growth drivers and challenges

The report segments the South America Neprilysin market as:

South America Neprilysin Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Brazil
Argentina
Venezuela
Colombia
Others

South America Neprilysin Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

TD-0714
STR-324
PL-265
LHW-090
Others

South America Neprilysin Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others

South America Neprilysin Market: Players Segment Analysis (Company and Product introduction, Neprilysin Sales Volume, Revenue, Price and Gross Margin):

Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEPRILYSIN

1.1 Definition of Neprilysin in This Report
1.2 Commercial Types of Neprilysin
  1.2.1 TD-0714
  1.2.2 STR-324
  1.2.3 PL-265
  1.2.4 LHW-090
  1.2.5 Others
1.3 Downstream Application of Neprilysin
  1.3.1 Acute Heart Failure
  1.3.2 Cancer Pain
  1.3.3 Hypertension
  1.3.4 Alzheimer's Disease
  1.3.5 Others
1.4 Development History of Neprilysin
1.5 Market Status and Trend of Neprilysin 2013-2023
  1.5.1 Europe Neprilysin Market Status and Trend 2013-2023
  1.5.2 Regional Neprilysin Market Status and Trend 2013-2023

CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Neprilysin in Europe 2013-2017
2.2 Consumption Market of Neprilysin in Europe by Regions
  2.2.1 Consumption Volume of Neprilysin in Europe by Regions
  2.2.2 Revenue of Neprilysin in Europe by Regions
2.3 Market Analysis of Neprilysin in Europe by Regions
  2.3.1 Market Analysis of Neprilysin in Germany 2013-2017
  2.3.2 Market Analysis of Neprilysin in United Kingdom 2013-2017
  2.3.3 Market Analysis of Neprilysin in France 2013-2017
  2.3.4 Market Analysis of Neprilysin in Italy 2013-2017
  2.3.5 Market Analysis of Neprilysin in Spain 2013-2017
  2.3.6 Market Analysis of Neprilysin in Benelux 2013-2017
  2.3.7 Market Analysis of Neprilysin in Russia 2013-2017
2.4 Market Development Forecast of Neprilysin in Europe 2018-2023
  2.4.1 Market Development Forecast of Neprilysin in Europe 2018-2023
  2.4.2 Market Development Forecast of Neprilysin by Regions 2018-2023

CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES

3.1 Whole Europe Market Status by Types
  3.1.1 Consumption Volume of Neprilysin in Europe by Types
  3.1.2 Revenue of Neprilysin in Europe by Types
3.2 Europe Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Germany
  3.2.2 Market Status by Types in United Kingdom
  3.2.3 Market Status by Types in France
  3.2.4 Market Status by Types in Italy
  3.2.5 Market Status by Types in Spain
  3.2.6 Market Status by Types in Benelux
  3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Neprilysin in Europe by Types

CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Neprilysin in Europe by Downstream Industry
4.2 Demand Volume of Neprilysin by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Neprilysin by Downstream Industry in Germany
  4.2.2 Demand Volume of Neprilysin by Downstream Industry in United Kingdom
  4.2.3 Demand Volume of Neprilysin by Downstream Industry in France
  4.2.4 Demand Volume of Neprilysin by Downstream Industry in Italy
  4.2.5 Demand Volume of Neprilysin by Downstream Industry in Spain
  4.2.6 Demand Volume of Neprilysin by Downstream Industry in Benelux
  4.2.7 Demand Volume of Neprilysin by Downstream Industry in Russia
4.3 Market Forecast of Neprilysin in Europe by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEPRILYSIN

5.1 Europe Economy Situation and Trend Overview
5.2 Neprilysin Downstream Industry Situation and Trend Overview

CHAPTER 6 NEPRILYSIN MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE

6.1 Sales Volume of Neprilysin in Europe by Major Players
6.2 Revenue of Neprilysin in Europe by Major Players
6.3 Basic Information of Neprilysin by Major Players
  6.3.1 Headquarters Location and Established Time of Neprilysin Major Players
  6.3.2 Employees and Revenue Level of Neprilysin Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 NEPRILYSIN MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Bioprojet SCR
  7.1.1 Company profile
  7.1.2 Representative Neprilysin Product
  7.1.3 Neprilysin Sales, Revenue, Price and Gross Margin of Bioprojet SCR
7.2 Novartis AG
  7.2.1 Company profile
  7.2.2 Representative Neprilysin Product
  7.2.3 Neprilysin Sales, Revenue, Price and Gross Margin of Novartis AG
7.3 Pharmaleads SA
  7.3.1 Company profile
  7.3.2 Representative Neprilysin Product
  7.3.3 Neprilysin Sales, Revenue, Price and Gross Margin of Pharmaleads SA
7.4 Theravance Biopharma Inc
  7.4.1 Company profile
  7.4.2 Representative Neprilysin Product
  7.4.3 Neprilysin Sales, Revenue, Price and Gross Margin of Theravance Biopharma Inc

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEPRILYSIN

8.1 Industry Chain of Neprilysin
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEPRILYSIN

9.1 Cost Structure Analysis of Neprilysin
9.2 Raw Materials Cost Analysis of Neprilysin
9.3 Labor Cost Analysis of Neprilysin
9.4 Manufacturing Expenses Analysis of Neprilysin

CHAPTER 10 MARKETING STATUS ANALYSIS OF NEPRILYSIN

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications